Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Galderma (UK) Ltd, Meridien House, 69-71 Clarendon Road, Watford, Herts, WD17 1DS, UK
Efracea 40 mg modified-release hard capsules.
Pharmaceutical Form |
---|
Modified-release hard capsule. Beige capsule, No. 2 size, bear the marking “GLD 40”. |
Each capsule contains 40 mg doxycycline (as monohydrate).
Excipients with known effect: 102-150 mg of sucrose and 26.6-29.4 μg of Allura red AC aluminium lake (E129).
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Doxycycline |
Doxycycline is primarily bacteriostatic and is believed to exert its antimicrobial effect by the inhibition of protein synthesis. |
List of Excipients |
---|
Capsule shell: Gelatin Capsule contents: Hypromellose |
Aluminium/PVC/Aclar blister.
Pack size:
56 capsules in 4 strips of 14 each
28 capsules in 2 strips of 14 each
14 capsules in 1 strip of 14
Not all pack sizes may be marketed.
Galderma (UK) Ltd, Meridien House, 69-71 Clarendon Road, Watford, Herts, WD17 1DS, UK
PL 10590/0056
2nd April 2009
Drug | Countries | |
---|---|---|
EFRACEA | Ireland, Netherlands, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.